Functional interactions between interleukin‐4, interleukin‐2, and tumor necrosis factor‐al for lymphokine‐activated killer cell generation
- 31 December 1989
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 4 (1) , 54-58
- https://doi.org/10.1002/jcla.1860040111
Abstract
The purpose of the present study was to explore the interaction between interleukin‐2 (IL‐2), interleukin‐4 (IL‐4), and tumor necrosis factor‐a (TNF) on the differentiation of human large granular lymphocytes (LGL) into lymphokine‐activated killer cells (LAK). The data show that recombinant human IL‐4 (100‐1,000 U/ml) was able to induce the differentiation of human LGL into LAK effectors. The levels of the IL‐4‐induced cytotoxicity are significantly lower than those observed after stimulation of LGL by optimal doses of IL‐2. This LAK activity generation by IL‐4 was not associated with LGL proliferation. When TNF was added in LGL culture in the presence of sub‐optimal concentrations of IL‐4, the lytic capacity of the activated killer cells was significantly enhanced, suggesting an apparent synergy between these two factors. Most interestingly, our data indicate that exogenous TNF can partially overcome the known inhibitory effect of IL‐4 on IL‐Pinduced LGL differentiation into LAK effectors. These findings suggest a role for TNF in the process of LAK induction.Keywords
This publication has 17 references indexed in Scilit:
- Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.Proceedings of the National Academy of Sciences, 1988
- Cachectin (Tumor Necrosis Factor): A Macrophage Hormone Governing Cellular Metabolism and Inflammatory ResponseEndocrine Reviews, 1988
- ‘Nonspecific’ MHC-unrestricted killer cells and their receptorsImmunology Today, 1987
- Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).The Journal of Experimental Medicine, 1987
- Recombinant interleukin 4 promotes the growth of human T cells.The Journal of Immunology, 1987
- Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.The Journal of Immunology, 1987
- Lymphokine-activated killer cells. Analysis of progenitors and effectors.The Journal of Experimental Medicine, 1986
- Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.The Journal of Experimental Medicine, 1986
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Identification of a T cell-derived b cell growth factor distinct from interleukin 2.The Journal of Experimental Medicine, 1982